Carlsbad, CA, October 12, 2006 - Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, today announced the appointment of Christopher P. Schnittker, CPA (38) to Senior Vice President and Chief Financial Officer. Mr. Schnittker has extensive experience in the financial management of publicly listed and privately held biotechnology and pharmaceutical companies. He will be based in the Washington, DC area and will be responsible for establishing Micromet's East Coast headquarters together with Matthias Alder, who was appointed as Senior Vice President, General Counsel and Secretary in July 2006.
